EyeWorld Weekly, January 22, 2021
➤ Enrollment complete for Phase 3 studies of investigational dry eye drug ➤ Update from two Glaukos trials ➤ Study: Remote monitoring with implantable IOP sensor affects clinical decision making ➤ ASCRS events
Browse articles from EyeWorld.org related to ASCRS. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Enrollment complete for Phase 3 studies of investigational dry eye drug ➤ Update from two Glaukos trials ➤ Study: Remote monitoring with implantable IOP sensor affects clinical decision making ➤ ASCRS events
➤ Commercial launch of Alcon’s Vivity IOL ➤ Topline results from Phase 2 trial for treatment of contact lens discomfort ➤ Company registers new artificial intelligence visual field exam device with FDA ➤ Positive Phase 3 results for faricimab for DME ➤ Research begins to create a MIGS patient-reported outcomes instrument ➤ ASCRS events
“In the day and age of refractive cataract surgery, optimizing outcomes is extremely important,” said Kathryn Hatch, MD, as she introduced a webinar hosted by the ASCRS Refractive Surgery Clinical Committee earlier this year. “We have increasing patient expectations, and it’s extremely important that we obtain ideal biometry measurements. To do so, we need to pay specific attention to the ocular surface, especially when treating astigmatism and presbyopia.”